文献速递胰腺与胆道疾病消化内镜

内镜下括约肌切开术联合胆道支架置入对不良事件风险的影响:随机对照试验的更新Meta分析

The addition of endoscopic sphincterotomy to biliary stent placement and its impact on the risk of adverse events: an updated meta-analysis of randomized controlled trials.
PubMed 文献 · Gastrointest Endosc · 2024-05-21

该系统评价纳入7项随机对照试验共1022例患者,比较胆道支架置入前是否行内镜下括约肌切开术(ES)对内镜逆行胰胆管造影术后不良事件的影响。结果显示ES组与非ES组术后胰腺炎发生率无显著差异,但ES组术后出血率显著升高。胆管炎、穿孔、支架/导管移位和闭塞发生率两组间无显著差异。

要点

  • ES组与非ES组术后胰腺炎发生率无显著差异(OR 0.46,95%CI 0.19-1.09,P=0.08)。
  • ES组术后出血率显著高于非ES组(OR 7.01,95%CI 2.24-21.99,P=0.0008)。
  • 胆管炎、穿孔、支架/导管移位和闭塞发生率两组间均无显著差异。

核心结论

  • 胆道引流前行内镜下括约肌切开术不影响术后胰腺炎发生率,但与术后出血率升高相关。

研究设计与样本

  • 系统检索PubMed、Embase和Cochrane数据库的随机对照试验,最终纳入7项随机对照试验共1022例患者,采用随机效应模型进行Meta分析,使用Review Manager 5.4进行统计分析。

主要发现

  • 术后胰腺炎:ES组与非ES组无显著差异(OR 0.46,95%CI 0.19-1.09,P=0.08,I²=59%)。
  • 术后出血:ES组显著高于非ES组(OR 7.01,95%CI 2.24-21.99,P=0.0008,I²=0%)。
  • 胆管炎:两组无显著差异(OR 1.25,95%CI 0.58-2.69,P=0.56,I²=67%)。
  • 穿孔:两组无显著差异(OR 1.95,95%CI 0.07-55.73,P=0.70,I²=58%)。
  • 支架/导管移位(OR 2.15,95%CI 0.61-7.57,P=0.23,I²=6%)和闭塞(OR 0.91,95%CI 0.37-2.25,P=0.84,I²=0%)两组间均无显著差异。

关键数值与推荐

  • 主要结局为术后胰腺炎(PEP),次要结局包括术后出血、穿孔、支架/导管闭塞、支架/导管移位和胆管炎。
  • 亚组分析针对因梗阻行胆道引流、使用金属支架和使用塑料支架的患者进行。
  • 异质性采用I²统计量检验,采用随机效应模型。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic sphincterotomy (ES) is not mandatory before biliary stenting. The impact of ES before biliary stent placement remains uncertain. Previous studies have reported that ES can increase adverse event rates by up to 4.5 times compared with no ES. We aimed to assess the occurrence of post-ERCP adverse events following biliary stent placement with and without ES. METHODS: PubMed, Embase, and Cochrane databases were systematically searched for randomized controlled trials. The primary outcome was post-ERCP pancreatitis (PEP). Subgroup analyses were performed with patients undergoing biliary drainage due to obstruction, using metal stents, and using plastic stents. Secondary outcomes were postprocedural bleeding, perforation, stent/catheter occlusion, stent/catheter migration, and cholangitis. Heterogeneity was examined with I2 statistics, and a random-effects model was used. Review Manager 5.4 was used for statistical analyses. RESULTS: Seven RCTs with 1022 patients were included. There was no significant difference between the ES and non-ES groups (odds ratio [OR], .46; 95% CI, .19-1.09; P = .08; I2 = 59%) regarding PEP; however, a significant difference in bleeding rates was found between groups, favoring non-ES (OR, 7.01; 95% CI, 2.24-21.99; P = .0008; I2 = 0%). The analysis of the occurrence of cholangitis (OR, 1.25; 95% CI, .58-2.69; P = .56; I2 = 67%), perforation (OR, 1.95; 95% CI, .07-55.73; P = .70; I2 = 58%), stent/catheter migration (OR, 2.15; 95% CI, .61-7.57; P = 0.23; I2 = 6%), and stent/catheter occlusion (OR, .91; 95% CI, .37-2.25; P = .84; I2 = 0%) did not favor either group. CONCLUSIONS: Performing ES before biliary drainage does not affect the PEP rate but is associated with an increased postprocedural bleeding rate.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Martins OC, Antunes V, Florêncio de Mesquita C, et al. The addition of endoscopic sphincterotomy to biliary stent placement and its impact on the risk of adverse events: an updated meta-analysis of randomized controlled trials. Gastrointest Endosc. 2024. PMID: 38782136. doi:10.1016/j.gie.2024.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。